Dr. Mahboob Rahman to Serve as Acting Nephrology Division Chief

The Department of Medicine is pleassed to announce that effective November 1, 2017, Dr. Mahboob Rahman, Professor of Medicine and Section Chief in Nephrology at the Louis Stokes Cleveland VA Medical Center, will become the Acting Division Chief in Nephrology & Hypertension at University Hospitals Cleveland Medical Center. Dr. Rahman has been an excellent leader and has accomplished many significant clinical and academic milestones at the VA. His vision and commitment has led Nephology to one of the top tier Sections in Medicine in the VA. His landmark studies in SPRINT and CRICK have had significant impact on the lives of our patients. Dr. Rahman is a tenured Professor of Medicine at Case Western Reserve University, and has been a member of the UH Cleveland Medical Center Division of Nephrology & Hypertension since 1997. He has served as the Chief of the section of Nephrology at the Louis Stokes Cleveland VA Medical Center since 2013. Dr. Rahman is nationally known for his research in hypertension and chronic kidney disease, and has published more than 140 papers in this field. He is a member of several national and international working groups advancing the care of patients with kidney disease and hypertension. He serves on three editorial boards, and is the Associate Editor of the Clinical Journal of the American Society of Nephrology.

The Department of Medicine is also delighted to announce that Dr. Niraj Desai, Assistant Professor of Medicine (Division of Nephrology & Hypertension) will become the new Section Chief at the Louis Stokes Cleveland VA Medical Center. Dr. Desai completed medical school at Northeastern Ohio University College of Medicine and did his residency at Rush University Medical Center, Chicago, IL. After residency, he became Associate Investigator, Vaccine Research Center Clinical Trials Core at the NIH and NIAID, in Bethesda, MD. In 2013, Dr. Desai came to our VA. He rapidly embraced the clinical, academic and administrative charge and became Associate Program Director of our Residency Program in the Internal Medicine and Nephrology & Hypertension Divisions. As a leader in academic Nephrology, Dr. Desai is the Principal Investigator of a SPARK-SEED-SPREAD VA Innovators Network Award in a project entitled "CKD Snapshot." He is also an investigator on the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease trial (ISCHEMIA-CKD) and a project entitled Efficacy and Safety of Finerenone in Subjects with Type 2 Diabetes Mellitus and Diabetic Kidney Disease (FIDELIO-DKD). In addition, Dr. Desai is the Primary Investigator of a program entitled "Stage of CKD and correlation to weight loss after enrollment in a weight loss program (MOVE!)"  Dr. Desai is also recognized for his publications and national and international presentations. Dr. Desai is a member of the American College of Physicians and the American Society of Nephrology.

The Department of Medicine would also like to express its gratitude and recognize Donald Hricik, MD, for his incredible contributions to the department over the years. Dr. Hricik is a graduate of the University of Notre Dame (1973, BS) and Georgetown University (1977, MD). He trained in internal medicine and nephrology at the Tufts New England Medical Center in Boston before joining the faculty at Case Western Reserve University in 1982. He has served as the Chief of the Division of Nephrology & Hypertension at UH Cleveland Medical Center since 1993. He currently serves as the Medical Director of the Kidney and Pancreas Transplantation Programs at UH Cleveland Medical Center. He was the Postgraduate Education Director for the American Society of Transplantation (AST) from 2001 to 2005 and also has served on the AST’s Board of Councilors. He was a member of the Nephrology Section of the American Board of Internal Medicine from 2002 to 2008. Dr. Hricik has served on the editorial boards of the Journal of the American Society of Nephrology, Transplantation, and Graft and served as an Associate Editor for the American Journal of Kidney Diseases and the Clinical Journal of the American Society of Nephrology. His research interests include side effects of immunosuppressive medications and immune monitoring of kidney transplant recipients. Dr. Hricik has been the recipient of NIH funding for 23 consecutive years, originally to clinically develop the ELISPOT assay for interferon gamma as a measure of alloreactivity in transplant recipients and more recently to serve as the Clinical Protocol Chair for three consecutive multicenter trials organized as part of the NIAID’s Clinical Trials in Organ Transplant initiative. He has published more than 190 peer-reviewed manuscripts and is the author or editor of a number of medical textbooks including Nephrology Secrets (three editions published in 11 languages), Hypertension Secrets, Repairing Body Fluids, Kidney Transplantation: State of the Art (two editions), and the third edition of the AST Primer. Dr. Hricik has published three novels:  “Racing to Pittsburgh” (2010),  “Nothing to Confess” (2013), and “Escape from Cleveland” (2016) all fictions with medical themes.

At UH Cleveland Medical Center, Dr. Hricik has trained more than 140 clinical fellows and established one of the nation’s first transplant nephrology training programs accredited by the AST. He was pivotal in developing the Department of Medicine’s first medical subspecialty ward, the Eckel Service, which served as the prototype for several subsequent subspecialty services. Dr. Hricik was named “Man of the Year” by the Kidney Foundation of Ohio in 2007. In 2012, he was named the “Center for Dialysis Care’s Leonard Rosenberg Master Clinician in Nephrology.” Dr. Hricik received the AST’s “Lifetime Achievement Award” in 2015 and will continue his clinical and academic activities in the Department of Medicine.